Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BLEOMYCIN Cause Acute myeloid leukaemia? 222 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 222 reports of Acute myeloid leukaemia have been filed in association with BLEOMYCIN (Bleomycin). This represents 3.2% of all adverse event reports for BLEOMYCIN.

222
Reports of Acute myeloid leukaemia with BLEOMYCIN
3.2%
of all BLEOMYCIN reports
118
Deaths
62
Hospitalizations

How Dangerous Is Acute myeloid leukaemia From BLEOMYCIN?

Of the 222 reports, 118 (53.2%) resulted in death, 62 (27.9%) required hospitalization, and 35 (15.8%) were considered life-threatening.

Is Acute myeloid leukaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 222 reports have been filed with the FAERS database.

What Other Side Effects Does BLEOMYCIN Cause?

Off label use (656) Febrile neutropenia (632) Neutropenia (433) Drug ineffective (395) Pyrexia (291) Product use in unapproved indication (280) Pulmonary toxicity (263) Thrombocytopenia (260) Nausea (255) Anaemia (252)

What Other Drugs Cause Acute myeloid leukaemia?

CYCLOPHOSPHAMIDE (1,675) VENETOCLAX (1,591) DOXORUBICIN (1,503) AZACITIDINE (1,156) ETOPOSIDE (1,069) VINCRISTINE (984) CYTARABINE (837) CARBOPLATIN (812) RITUXIMAB (735) METHOTREXATE (728)

Which BLEOMYCIN Alternatives Have Lower Acute myeloid leukaemia Risk?

BLEOMYCIN vs BLINATUMOMAB BLEOMYCIN vs BLONANSERIN BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLEOMYCIN vs BOCEPREVIR BLEOMYCIN vs BOCOCIZUMAB

Related Pages

BLEOMYCIN Full Profile All Acute myeloid leukaemia Reports All Drugs Causing Acute myeloid leukaemia BLEOMYCIN Demographics